Replies to post #27535 on Relief Therapeutics Holding AG (RLFTF)

[PennyWorld]

There is always the likelihood that a handful of the prevailing therapeutics soon coming to market will dramatically reduce the occurrences of patients progressing to ... critically ill and on vents.

If that occurs, that is a very good thing for COVID patients. However, it could also dramatically reduce the demand/need for RFL-100, per the current Phase 2/3 trials.

Counter arguments are welcome!!

[aGuyUS]

I am just hoping that with the FDA moving past Remdesivir, RLF100 will get a FDA admin to start working on it's EUA .